1. Homepage
  2. Equities
  3. Canada
  4. Bourse de Toronto
  5. Indiva Limited
  6. Summary
    NDVA   CA45580J1012

INDIVA LIMITED

(NDVA)
  Report
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Bourse De Toronto
05/18/2022 05/19/2022 05/20/2022 05/24/2022 05/25/2022 Date
0.25(c) 0.235(c) 0.23(c) 0.21(c) 0.215 Last
96 557 85 007 79 981 147 738 29 000 Volume
0.00% -6.00% -2.13% -8.70% +2.38% Change
More quotes
Estimated financial data (e)
Sales 2022 45,7 M 35,6 M 35,6 M
Net income 2022 -24,4 M -19,0 M -19,0 M
Net Debt 2022 23,2 M 18,1 M 18,1 M
P/E ratio 2022 -5,25x
Yield 2022 -
Sales 2023 68,3 M 53,2 M 53,2 M
Net income 2023 -14,0 M -10,9 M -10,9 M
Net Debt 2023 17,4 M 13,6 M 13,6 M
P/E ratio 2023 -4,67x
Yield 2023 -
Capitalization 30,7 M 23,9 M 23,9 M
EV / Sales 2022 1,18x
EV / Sales 2023 0,70x
Nbr of Employees -
Free-Float 71,9%
More Financials
Company
Indiva Limited is a Canada-based company, which is engaged in the production, processing, and sale of cannabis and cannabis-related products. The Company creates premium cannabis capsules, whole flower, pre-rolls, and provides production and manufacturing services to peer entities. The Company produces, distributes, and markets Indiva, Artisan Batch, Bhang Chocolate, Gron Pearls & Pips, Wana Sour Gummies, Jewels... 
Sector
Pharmaceuticals
Calendar
06/23 | 04:00pmShareholder meeting
More about the company
Ratings of Indiva Limited
Trading Rating :  -
Investor Rating : 
ESG Refinitiv : 
-
More Ratings
All news about INDIVA LIMITED
05/19Indiva Q1 Loss $0.02 Per Share Vs Loss $0.03 Year Ago; Net Revenue Increases 44%; Provi..
MT
05/19TRANSCRIPT : Indiva Limited, Q1 2022 Earnings Call, May 19, 2022
CI
05/19Indiva Limited Provides Revenue Guidance for the Second Quarter of 2022
CI
05/18Indiva Limited Reports Earnings Results for the First Quarter Ended March 31, 2022
CI
05/02TRANSCRIPT : Indiva Limited - Analyst/Investor Day
CI
04/26TRANSCRIPT : Indiva Limited, Q4 2021 Earnings Call, Apr 26, 2022
CI
04/26Indiva Limited Reports Earnings Results for the Full Year Ended December 31, 2021
CI
04/26Indiva Limited Provides Net Revenue Guidance for the First Quarter of 2022
CI
04/26Indiva reports record fourth quarter and fiscal year 2021 results
AQ
04/26Indiva Limited Auditor Raises 'Going Concern' Doubt
CI
04/19Indiva to Manufacture and Distribute Dime Industry Cannabis Vaping Products in Canada
MT
04/19Indiva signs exclusive licensing and manufacturing agreement with dime industries
PR
04/19Indiva Signs Exclusive Licensing and Manufacturing Agreement with Dime Industries
CI
04/18INDIVA LIMITED(TSXV : NDVA) dropped from S&P/TSX Venture Composite Index
CI
04/13Canntab Engages Hamish Sutherland as Strategic Advisor
PR
More news
News in other languages on INDIVA LIMITED
05/19Indiva enregistre une perte de 0,02 $ par action au premier trimestre, contre une perte..
05/19Indiva Limited fournit des prévisions de revenus pour le deuxième trimestre de 2022
05/18Indiva Limited annonce ses résultats pour le premier trimestre clos le 31 mars 2022
04/26Indiva Limited annonce ses résultats pour l'exercice complet clos le 31 décembre 2021
04/26Indiva Limited fournit des prévisions de revenus nets pour le premier trimestre de 2022
More news
Analyst Recommendations on INDIVA LIMITED
More recommendations
Chart INDIVA LIMITED
Duration : Period :
Indiva Limited Technical Analysis Chart | NDVA | CA45580J1012 | MarketScreener
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 2
Last Close Price 0,21 CAD
Average target price 0,55 CAD
Spread / Average Target 162%
EPS Revisions
Managers and Directors
Carmine Edward Marotta President, Chief Executive Officer & Director
Jennifer Ann Welsh Chief Financial Officer
Robert William Carse Chief Operating Officer
Andre Lafleche Independent Director
James Yersh Independent Director